BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cani PD, Plovier H, Van Hul M, Geurts L, Delzenne NM, Druart C, Everard A. Endocannabinoids — at the crossroads between the gut microbiota and host metabolism. Nat Rev Endocrinol 2016;12:133-43. [DOI: 10.1038/nrendo.2015.211] [Cited by in Crossref: 161] [Cited by in F6Publishing: 154] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Ellis RJ, Wilson N, Peterson S. Cannabis and Inflammation in HIV: A Review of Human and Animal Studies. Viruses 2021;13:1521. [PMID: 34452386 DOI: 10.3390/v13081521] [Reference Citation Analysis]
2 Hasenoehrl C, Taschler U, Storr M, Schicho R. The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. Neurogastroenterol Motil 2016;28:1765-80. [PMID: 27561826 DOI: 10.1111/nmo.12931] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 9.7] [Reference Citation Analysis]
3 Osafo N, Yeboah OK, Antwi AO. Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation. Mol Biol Rep 2021;48:3665-80. [PMID: 33909195 DOI: 10.1007/s11033-021-06366-1] [Reference Citation Analysis]
4 Osman M, Papon N, Weill FX. Endocannabinoids Attenuate the Virulence of Certain Enteropathogenic Bacteria. Trends Microbiol 2021;29:185-7. [PMID: 33388214 DOI: 10.1016/j.tim.2020.12.008] [Reference Citation Analysis]
5 Lee Y, Jo J, Chung HY, Pothoulakis C, Im E. Endocannabinoids in the gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol 2016;311:G655-66. [PMID: 27538961 DOI: 10.1152/ajpgi.00294.2015] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
6 Gamage HKAH, Tetu SG, Chong RWW, Bucio-Noble D, Rosewarne CP, Kautto L, Ball MS, Molloy MP, Packer NH, Paulsen IT. Fiber Supplements Derived From Sugarcane Stem, Wheat Dextrin and Psyllium Husk Have Different In Vitro Effects on the Human Gut Microbiota. Front Microbiol 2018;9:1618. [PMID: 30072976 DOI: 10.3389/fmicb.2018.01618] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wang X, Liu D, Wang Z, Cai C, Jiang H, Yu G. Porphyran-derived oligosaccharides alleviate NAFLD and related cecal microbiota dysbiosis in mice. FASEB J 2021;35:e21458. [PMID: 33948987 DOI: 10.1096/fj.202000763RRR] [Reference Citation Analysis]
8 Saloner R, Fields JA, Marcondes MCG, Iudicello JE, von Känel S, Cherner M, Letendre SL, Kaul M, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group. Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior. J Neuroimmune Pharmacol 2020;15:743-64. [PMID: 32929575 DOI: 10.1007/s11481-020-09957-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
9 Abolghasemi A, Manca C, Iannotti FA, Shen M, Leblanc N, Lacroix S, Martin C, Flamand N, Di Marzo V, Silvestri C. Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis. Int J Mol Sci 2021;22:12361. [PMID: 34830242 DOI: 10.3390/ijms222212361] [Reference Citation Analysis]
10 Shore SA, Cho Y. Obesity and Asthma: Microbiome-Metabolome Interactions. Am J Respir Cell Mol Biol 2016;54:609-17. [PMID: 26949916 DOI: 10.1165/rcmb.2016-0052PS] [Cited by in Crossref: 43] [Cited by in F6Publishing: 25] [Article Influence: 8.6] [Reference Citation Analysis]
11 Hussein HM, Elyamany MF, Rashed LA, Sallam NA. Vitamin D mitigates diabetes-associated metabolic and cognitive dysfunction by modulating gut microbiota and colonic cannabinoid receptor 1. Eur J Pharm Sci 2021;:106105. [PMID: 34942358 DOI: 10.1016/j.ejps.2021.106105] [Reference Citation Analysis]
12 Plovier H, Cani PD, Britton RA, Cani PD. Microbial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders? Microbiol Spectr 2017;5. [DOI: 10.1128/microbiolspec.bad-0002-2016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
13 Jug U, Naumoska K, Metličar V, Schink A, Makuc D, Vovk I, Plavec J, Lucas K. Interference of oleamide with analytical and bioassay results. Sci Rep 2020;10:2163. [PMID: 32034225 DOI: 10.1038/s41598-020-59093-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
14 Ballini A, Scacco S, Boccellino M, Santacroce L, Arrigoni R. Microbiota and Obesity: Where Are We Now? Biology (Basel) 2020;9:E415. [PMID: 33255588 DOI: 10.3390/biology9120415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
15 Kang C, Wang B, Kaliannan K, Wang X, Lang H, Hui S, Huang L, Zhang Y, Zhou M, Chen M, Mi M. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet. mBio 2017;8:e00470-17. [PMID: 28536285 DOI: 10.1128/mBio.00470-17] [Cited by in Crossref: 60] [Cited by in F6Publishing: 52] [Article Influence: 12.0] [Reference Citation Analysis]
16 Yilmaz M, Claiborn KC, Hotamisligil GS. De Novo Lipogenesis Products and Endogenous Lipokines. Diabetes 2016;65:1800-7. [PMID: 27288005 DOI: 10.2337/db16-0251] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
17 Esposito G, Pesce M, Seguella L, Lu J, Corpetti C, Del Re A, De Palma FDE, Esposito G, Sanseverino W, Sarnelli G. Engineered Lactobacillus paracasei Producing Palmitoylethanolamide (PEA) Prevents Colitis in Mice. Int J Mol Sci 2021;22:2945. [PMID: 33799405 DOI: 10.3390/ijms22062945] [Reference Citation Analysis]
18 DiPatrizio NV. Endocannabinoids and the Gut-Brain Control of Food Intake and Obesity. Nutrients 2021;13:1214. [PMID: 33916974 DOI: 10.3390/nu13041214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
19 Lian J, Casari I, Falasca M. Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract. Pharmacol Res 2021;175:106025. [PMID: 34883211 DOI: 10.1016/j.phrs.2021.106025] [Reference Citation Analysis]
20 Grill M, Hasenoehrl C, Storr M, Schicho R. Medical Cannabis and Cannabinoids: An Option for the Treatment of Inflammatory Bowel Disease and Cancer of the Colon? Med Cannabis Cannabinoids 2018;1:28-35. [PMID: 34676319 DOI: 10.1159/000489036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Rastelli M, Cani PD, Knauf C. The Gut Microbiome Influences Host Endocrine Functions. Endocr Rev 2019;40:1271-84. [PMID: 31081896 DOI: 10.1210/er.2018-00280] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 28.0] [Reference Citation Analysis]
22 Xu H, Wang X, Feng W, Liu Q, Zhou S, Liu Q, Cai L. The gut microbiota and its interactions with cardiovascular disease. Microb Biotechnol 2020;13:637-56. [PMID: 31984651 DOI: 10.1111/1751-7915.13524] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
23 Chevalier G, Siopi E, Guenin-Macé L, Pascal M, Laval T, Rifflet A, Boneca IG, Demangel C, Colsch B, Pruvost A, Chu-Van E, Messager A, Leulier F, Lepousez G, Eberl G, Lledo PM. Effect of gut microbiota on depressive-like behaviors in mice is mediated by the endocannabinoid system. Nat Commun 2020;11:6363. [PMID: 33311466 DOI: 10.1038/s41467-020-19931-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 12.5] [Reference Citation Analysis]
24 Depommier C, Flamand N, Pelicaen R, Maiter D, Thissen JP, Loumaye A, Hermans MP, Everard A, Delzenne NM, Di Marzo V, Cani PD. Linking the Endocannabinoidome with Specific Metabolic Parameters in an Overweight and Insulin-Resistant Population: From Multivariate Exploratory Analysis to Univariate Analysis and Construction of Predictive Models. Cells 2021;10:E71. [PMID: 33466285 DOI: 10.3390/cells10010071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Wang Z, Zhang W, Wang B, Zhang F, Shao Y. Influence of Bactrian camel milk on the gut microbiota. J Dairy Sci 2018;101:5758-69. [PMID: 29705422 DOI: 10.3168/jds.2017-13860] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
26 Tao K, Zhu J, Wei K, Meng X, Zhu M, Tao Y, Lu Z, Yu W. Cannabinoid Receptor-2 Activation in Keratinocytes Contributes to Elevated Peripheral β-Endorphin Levels in Patients With Obstructive Jaundice. Anesth Analg 2021;133:251-62. [PMID: 33560661 DOI: 10.1213/ANE.0000000000005405] [Reference Citation Analysis]
27 González-García I, Tena-Sempere M, López M. Estradiol Regulation of Brown Adipose Tissue Thermogenesis. Adv Exp Med Biol 2017;1043:315-35. [PMID: 29224101 DOI: 10.1007/978-3-319-70178-3_15] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
28 Alghamdi MA, Redwan EM. Interplay of Microbiota and Citrullination in the Immunopathogenesis of Rheumatoid Arthritis. Probiotics Antimicrob Proteins 2021. [PMID: 34036479 DOI: 10.1007/s12602-021-09802-7] [Reference Citation Analysis]
29 Madsen L, Myrmel LS, Fjære E, Liaset B, Kristiansen K. Links between Dietary Protein Sources, the Gut Microbiota, and Obesity. Front Physiol 2017;8:1047. [PMID: 29311977 DOI: 10.3389/fphys.2017.01047] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
30 Guida F, Boccella S, Belardo C, Iannotta M, Piscitelli F, De Filippis F, Paino S, Ricciardi F, Siniscalco D, Marabese I, Luongo L, Ercolini D, Di Marzo V, Maione S. Altered gut microbiota and endocannabinoid system tone in vitamin D deficiency-mediated chronic pain. Brain Behav Immun 2020;85:128-41. [PMID: 30953765 DOI: 10.1016/j.bbi.2019.04.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
31 Naumoska K, Jug U, Metličar V, Vovk I. Oleamide, a Bioactive Compound, Unwittingly Introduced into the Human Body through Some Plastic Food/Beverages and Medicine Containers. Foods 2020;9:E549. [PMID: 32369935 DOI: 10.3390/foods9050549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Liu Y, Yao Y, Li H, Qiao F, Wu J, Du ZY, Zhang M. Influence of Endogenous and Exogenous Estrogenic Endocrine on Intestinal Microbiota in Zebrafish. PLoS One 2016;11:e0163895. [PMID: 27701432 DOI: 10.1371/journal.pone.0163895] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
33 Ghaffari S, Abbasi A, Somi MH, Moaddab SY, Nikniaz L, Kafil HS, Ebrahimzadeh Leylabadlo H. Akkermansia muciniphila: from its critical role in human health to strategies for promoting its abundance in human gut microbiome. Crit Rev Food Sci Nutr 2022;:1-21. [PMID: 35238258 DOI: 10.1080/10408398.2022.2045894] [Reference Citation Analysis]
34 Batugedara HM, Argueta D, Jang JC, Lu D, Macchietto M, Kaur J, Ge S, Dillman AR, DiPatrizio NV, Nair MG. Host- and Helminth-Derived Endocannabinoids That Have Effects on Host Immunity Are Generated during Infection. Infect Immun 2018;86:e00441-18. [PMID: 30104215 DOI: 10.1128/IAI.00441-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
35 Yu KB, Hsiao EY. Roles for the gut microbiota in regulating neuronal feeding circuits. J Clin Invest 2021;131:143772. [PMID: 33998595 DOI: 10.1172/JCI143772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Khan RN, Maner-Smith K, A Owens J, Barbian ME, M Jones R, R Naudin C. At the heart of microbial conversations: endocannabinoids and the microbiome in cardiometabolic risk. Gut Microbes 2021;13:1-21. [PMID: 33896380 DOI: 10.1080/19490976.2021.1911572] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, Han D, Cha KH, Moon SH, Lee K, Kim YJ, Lee SJ, Nam TW, Ko G. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6:563-573. [PMID: 33820962 DOI: 10.1038/s41564-021-00880-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
38 Covasa M, Stephens RW, Toderean R, Cobuz C. Intestinal Sensing by Gut Microbiota: Targeting Gut Peptides. Front Endocrinol (Lausanne) 2019;10:82. [PMID: 30837951 DOI: 10.3389/fendo.2019.00082] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 10.7] [Reference Citation Analysis]
39 Baritaki S, de Bree E, Chatzaki E, Pothoulakis C. Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk. J Clin Med 2019;8:E1669. [PMID: 31614860 DOI: 10.3390/jcm8101669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
40 Chen M, Hui S, Lang H, Zhou M, Zhang Y, Kang C, Zeng X, Zhang Q, Yi L, Mi M. SIRT3 Deficiency Promotes High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease in Correlation with Impaired Intestinal Permeability through Gut Microbial Dysbiosis. Mol Nutr Food Res 2019;63:e1800612. [PMID: 30525304 DOI: 10.1002/mnfr.201800612] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 6.8] [Reference Citation Analysis]
41 Guida F, Turco F, Iannotta M, De Gregorio D, Palumbo I, Sarnelli G, Furiano A, Napolitano F, Boccella S, Luongo L, Mazzitelli M, Usiello A, De Filippis F, Iannotti FA, Piscitelli F, Ercolini D, de Novellis V, Di Marzo V, Cuomo R, Maione S. Antibiotic-induced microbiota perturbation causes gut endocannabinoidome changes, hippocampal neuroglial reorganization and depression in mice. Brain Behav Immun 2018;67:230-45. [PMID: 28890155 DOI: 10.1016/j.bbi.2017.09.001] [Cited by in Crossref: 106] [Cited by in F6Publishing: 103] [Article Influence: 21.2] [Reference Citation Analysis]
42 Kwan Cheung KA, Mitchell MD, Heussler HS. Cannabidiol and Neurodevelopmental Disorders in Children. Front Psychiatry 2021;12:643442. [PMID: 34093265 DOI: 10.3389/fpsyt.2021.643442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Hasenoehrl C, Storr M, Schicho R. Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? Expert Rev Gastroenterol Hepatol 2017;11:329-37. [PMID: 28276820 DOI: 10.1080/17474124.2017.1292851] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
44 Cherkasova V, Kovalchuk O, Kovalchuk I. Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer. Cancers (Basel) 2021;13:4353. [PMID: 34503163 DOI: 10.3390/cancers13174353] [Reference Citation Analysis]
45 Papadopoulos PD, Tsigalou C, Valsamaki PN, Konstantinidis TG, Voidarou C, Bezirtzoglou E. The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives. Biomedicines 2022;10:948. [DOI: 10.3390/biomedicines10050948] [Reference Citation Analysis]
46 Lee P, Teng C, Kalyanam N, Ho C, Pan M. Garcinol Reduces Obesity in High‐Fat‐Diet‐Fed Mice by Modulating Gut Microbiota Composition. Mol Nutr Food Res 2019;63:1800390. [DOI: 10.1002/mnfr.201800390] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
47 Koto A, Nobu MK, Miyazaki R. Deep Sequencing Uncovers Caste-Associated Diversity of Symbionts in the Social Ant Camponotus japonicus. mBio 2020;11:e00408-20. [PMID: 32317320 DOI: 10.1128/mBio.00408-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Busquets Garcia A, Soria-Gomez E, Bellocchio L, Marsicano G. Cannabinoid receptor type-1: breaking the dogmas. F1000Res 2016;5:F1000 Faculty Rev-990. [PMID: 27239293 DOI: 10.12688/f1000research.8245.1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
49 Lefort C, Cani PD. The Liver under the Spotlight: Bile Acids and Oxysterols as Pivotal Actors Controlling Metabolism. Cells 2021;10:400. [PMID: 33669184 DOI: 10.3390/cells10020400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Sionov RV, Steinberg D. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles. Biomedicines 2022;10:631. [DOI: 10.3390/biomedicines10030631] [Reference Citation Analysis]
51 Lau BK, Cota D, Cristino L, Borgland SL. Endocannabinoid modulation of homeostatic and non-homeostatic feeding circuits. Neuropharmacology 2017;124:38-51. [PMID: 28579186 DOI: 10.1016/j.neuropharm.2017.05.033] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 9.0] [Reference Citation Analysis]
52 Manca C, Shen M, Boubertakh B, Martin C, Flamand N, Silvestri C, Di Marzo V. Alterations of brain endocannabinoidome signaling in germ-free mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020;1865:158786. [DOI: 10.1016/j.bbalip.2020.158786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
53 Pendharkar SA, Walia M, Drury M, Petrov MS. Calcitonin gene-related peptide: neuroendocrine communication between the pancreas, gut, and brain in regulation of blood glucose. Ann Transl Med 2017;5:419. [PMID: 29201871 DOI: 10.21037/atm.2017.08.27] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
54 Cha KH, Lee EH, Yoon HS, Lee JH, Kim JY, Kang K, Park JS, Jin JB, Ko G, Pan CH. Effects of fermented milk treatment on microbial population and metabolomic outcomes in a three-stage semi-continuous culture system. Food Chem 2018;263:216-24. [PMID: 29784310 DOI: 10.1016/j.foodchem.2018.04.095] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
55 Teper Y, Eibl G. Pancreatic Macrophages: Critical Players in Obesity-Promoted Pancreatic Cancer. Cancers (Basel) 2020;12:E1946. [PMID: 32709161 DOI: 10.3390/cancers12071946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
56 Lefort C, Roumain M, Van Hul M, Rastelli M, Manco R, Leclercq I, Delzenne NM, Marzo VD, Flamand N, Luquet S, Silvestri C, Muccioli GG, Cani PD. Hepatic NAPE-PLD Is a Key Regulator of Liver Lipid Metabolism. Cells 2020;9:E1247. [PMID: 32443626 DOI: 10.3390/cells9051247] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
57 Niccolai E, Boem F, Russo E, Amedei A. The Gut⁻Brain Axis in the Neuropsychological Disease Model of Obesity: A Classical Movie Revised by the Emerging Director "Microbiome". Nutrients 2019;11:E156. [PMID: 30642052 DOI: 10.3390/nu11010156] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
58 Mo J, Gao L, Zhang N, Xie J, Li D, Shan T, Fan L. Structural and quantitative alterations of gut microbiota in experimental small bowel obstruction. PLoS One 2021;16:e0255651. [PMID: 34347831 DOI: 10.1371/journal.pone.0255651] [Reference Citation Analysis]
59 Fornelos N, Franzosa EA, Bishai J, Annand JW, Oka A, Lloyd-Price J, Arthur TD, Garner A, Avila-Pacheco J, Haiser HJ, Tolonen AC, Porter JA, Clish CB, Sartor RB, Huttenhower C, Vlamakis H, Xavier RJ. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease. Nat Microbiol 2020;5:486-97. [PMID: 31959971 DOI: 10.1038/s41564-019-0655-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
60 DiPatrizio NV. Endocannabinoids in the Gut. Cannabis Cannabinoid Res 2016;1:67-77. [PMID: 27413788 DOI: 10.1089/can.2016.0001] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
61 Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 2020;16:9-29. [DOI: 10.1038/s41582-019-0284-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 136] [Article Influence: 49.3] [Reference Citation Analysis]
62 Di Marzo V. The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
. Dialogues Clin Neurosci 2020;22:259-69. [PMID: 33162769 DOI: 10.31887/DCNS.2020.22.3/vdimarzo] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
63 Mokkala K, Houttu N, Cansev T, Laitinen K. Interactions of dietary fat with the gut microbiota: Evaluation of mechanisms and metabolic consequences. Clinical Nutrition 2020;39:994-1018. [DOI: 10.1016/j.clnu.2019.05.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 13.5] [Reference Citation Analysis]
64 Han JH, Kim W. Peripheral CB1R as a modulator of metabolic inflammation. FASEB J 2021;35:e21232. [PMID: 33715173 DOI: 10.1096/fj.202001960R] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Lamichhane S, Sen P, Alves MA, Ribeiro HC, Raunioniemi P, Hyötyläinen T, Orešič M. Linking Gut Microbiome and Lipid Metabolism: Moving beyond Associations. Metabolites 2021;11:55. [PMID: 33467644 DOI: 10.3390/metabo11010055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Velásquez-Mejía EP, Carmona JA, Abad JM, Escobar JS. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut. Diabetes Care. 2017;40:54-62. [PMID: 27999002 DOI: 10.1155/2016/7030795] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
67 Cornelis MC, Erlund I, Michelotti GA, Herder C, Westerhuis JA, Tuomilehto J. Metabolomic response to coffee consumption: application to a three-stage clinical trial. J Intern Med 2018;283:544-57. [DOI: 10.1111/joim.12737] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
68 Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol Gastrointest Liver Physiol. 2017;312:G413-G419. [PMID: 28232456 DOI: 10.1152/ajpgi.00361.2016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 13.6] [Reference Citation Analysis]
69 Chiurchiù V, Leuti A, Maccarrone M. Bioactive Lipids and Chronic Inflammation: Managing the Fire Within. Front Immunol 2018;9:38. [PMID: 29434586 DOI: 10.3389/fimmu.2018.00038] [Cited by in Crossref: 140] [Cited by in F6Publishing: 127] [Article Influence: 35.0] [Reference Citation Analysis]
70 Cao W, Li RW, Chin Y, Wang Y, Xue C, Tang Q. Transcriptome analysis reveals the protective role of fructo-oligosaccharide in colonic mucosal barriers in exercise-induced stressed mice. Food Funct 2021;12:4484-95. [PMID: 33885098 DOI: 10.1039/d0fo02556a] [Reference Citation Analysis]
71 Cinar R, Iyer MR, Kunos G. The therapeutic potential of second and third generation CB1R antagonists. Pharmacology & Therapeutics 2020;208:107477. [DOI: 10.1016/j.pharmthera.2020.107477] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 13.0] [Reference Citation Analysis]
72 Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. 2018;1693:128-133. [PMID: 29903615 DOI: 10.1016/j.brainres.2018.03.015] [Cited by in Crossref: 252] [Cited by in F6Publishing: 240] [Article Influence: 84.0] [Reference Citation Analysis]
73 Sharkey KA. Targeting the gut to treat obesity and its metabolic consequences: view from the Chair. Int J Obes Suppl 2016;6:S3-5. [PMID: 28685022 DOI: 10.1038/ijosup.2016.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Chia CW, Egan JM. Incretins in obesity and diabetes. Ann N Y Acad Sci. 2020;1461:104-126. [PMID: 31392745 DOI: 10.1111/nyas.14211] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
75 Jansma J, Brinkman F, van Hemert S, El Aidy S. Targeting the endocannabinoid system with microbial interventions to improve gut integrity. Prog Neuropsychopharmacol Biol Psychiatry 2021;106:110169. [PMID: 33186639 DOI: 10.1016/j.pnpbp.2020.110169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
76 Clark TM. Scoping Review and Meta-Analysis Suggests that Cannabis Use May Reduce Cancer Risk in the United States. Cannabis Cannabinoid Res 2021;6:413-34. [PMID: 33998861 DOI: 10.1089/can.2019.0095] [Reference Citation Analysis]
77 López M, Tena-Sempere M. Estradiol and brown fat. Best Pract Res Clin Endocrinol Metab 2016;30:527-36. [PMID: 27697213 DOI: 10.1016/j.beem.2016.08.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
78 Duarte-Silva E, de Melo MG, Maes M, Filho AJMC, Macedo D, Peixoto CA. Shared metabolic and neuroimmune mechanisms underlying Type 2 Diabetes Mellitus and Major Depressive Disorder. Prog Neuropsychopharmacol Biol Psychiatry 2021;111:110351. [PMID: 34000290 DOI: 10.1016/j.pnpbp.2021.110351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Kienzl M, Storr M, Schicho R. Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases. Clin Transl Gastroenterol 2020;11:e00120. [PMID: 31899693 DOI: 10.14309/ctg.0000000000000120] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
80 Natale NR, Kent M, Fox N, Vavra D, Lambert K. Neurobiological effects of a probiotic-supplemented diet in chronically stressed male Long-Evans rats: Evidence of enhanced resilience. IBRO Neurosci Rep 2021;11:207-15. [PMID: 34849506 DOI: 10.1016/j.ibneur.2021.10.004] [Reference Citation Analysis]
81 Michels N. Biological underpinnings from psychosocial stress towards appetite and obesity during youth: research implications towards metagenomics, epigenomics and metabolomics. Nutr Res Rev 2019;32:282-93. [PMID: 31298176 DOI: 10.1017/S0954422419000143] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
82 Everard A, Plovier H, Rastelli M, Van Hul M, de Wouters d'Oplinter A, Geurts L, Druart C, Robine S, Delzenne NM, Muccioli GG, de Vos WM, Luquet S, Flamand N, Di Marzo V, Cani PD. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nat Commun 2019;10:457. [PMID: 30692526 DOI: 10.1038/s41467-018-08051-7] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
83 Zou S, Fang L, Lee MH. Dysbiosis of gut microbiota in promoting the development of colorectal cancer. Gastroenterol Rep (Oxf). 2018;6:1-12. [PMID: 29479437 DOI: 10.1093/gastro/gox031] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 17.2] [Reference Citation Analysis]
84 Horn H, Böhme B, Dietrich L, Koch M. Endocannabinoids in Body Weight Control. Pharmaceuticals (Basel) 2018;11:E55. [PMID: 29849009 DOI: 10.3390/ph11020055] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
85 Rastelli M, Knauf C, Cani PD. Gut Microbes and Health: A Focus on the Mechanisms Linking Microbes, Obesity, and Related Disorders. Obesity (Silver Spring). 2018;26:792-800. [PMID: 29687645 DOI: 10.1002/oby.22175] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 18.0] [Reference Citation Analysis]
86 Konieczka P, Szkopek D, Kinsner M, Fotschki B, Juśkiewicz J, Banach J. Cannabis-derived cannabidiol and nanoselenium improve gut barrier function and affect bacterial enzyme activity in chickens subjected to C. perfringens challenge. Vet Res 2020;51:141. [PMID: 33225993 DOI: 10.1186/s13567-020-00863-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
87 Kim D, Min Y, Yang J, Heo Y, Kim M, Hur CG, Lee SC, Lee HK, Song KD, Heo J, Son YO, Lee DS. Multi-Probiotic Lactobacillus Supplementation Improves Liver Function and Reduces Cholesterol Levels in Jeju Native Pigs. Animals (Basel) 2021;11:2309. [PMID: 34438766 DOI: 10.3390/ani11082309] [Reference Citation Analysis]
88 Cani PD, de Vos WM. Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila. Front Microbiol. 2017;8:1765. [PMID: 29018410 DOI: 10.3389/fmicb.2017.01765] [Cited by in Crossref: 339] [Cited by in F6Publishing: 313] [Article Influence: 67.8] [Reference Citation Analysis]
89 Manca C, Lacroix S, Pérusse F, Flamand N, Chagnon Y, Drapeau V, Tremblay A, Di Marzo V, Silvestri C. Oral Capsaicinoid Administration Alters the Plasma Endocannabinoidome and Fecal Microbiota of Reproductive-Aged Women Living with Overweight and Obesity. Biomedicines 2021;9:1246. [PMID: 34572432 DOI: 10.3390/biomedicines9091246] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Ijaz MU, Ahmad MI, Hussain M, Khan IA, Zhao D, Li C. Meat Protein in High-Fat Diet Induces Adipogensis and Dyslipidemia by Altering Gut Microbiota and Endocannabinoid Dysregulation in the Adipose Tissue of Mice. J Agric Food Chem 2020;68:3933-46. [PMID: 32148030 DOI: 10.1021/acs.jafc.0c00017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
91 Castonguay-Paradis S, Lacroix S, Rochefort G, Parent L, Perron J, Martin C, Lamarche B, Raymond F, Flamand N, Di Marzo V, Veilleux A. Dietary fatty acid intake and gut microbiota determine circulating endocannabinoidome signaling beyond the effect of body fat. Sci Rep 2020;10:15975. [PMID: 32994521 DOI: 10.1038/s41598-020-72861-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
92 Baban B, Khodadadi H, Salles ÉL, Costigliola V, Morgan JC, Hess DC, Vaibhav K, Dhandapani KM, Yu JC. Inflammaging and Cannabinoids. Ageing Res Rev 2021;72:101487. [PMID: 34662745 DOI: 10.1016/j.arr.2021.101487] [Reference Citation Analysis]
93 Meijerink J. The Intestinal Fatty Acid-Enteroendocrine Interplay, Emerging Roles for Olfactory Signaling and Serotonin Conjugates. Molecules 2021;26:1416. [PMID: 33807994 DOI: 10.3390/molecules26051416] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
94 Marion-Letellier R, Leboutte M, Amamou A, Raman M, Savoye G, Ghosh S. Diet in Intestinal Fibrosis: A Double-Edged Sword. Nutrients 2021;13:3148. [PMID: 34579023 DOI: 10.3390/nu13093148] [Reference Citation Analysis]
95 Pei R, Dimarco DM, Putt KK, Martin DA, Gu Q, Chitchumroonchokchai C, White HM, Scarlett CO, Bruno RS, Bolling BW. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial. Br J Nutr 2017;118:1043-51. [DOI: 10.1017/s0007114517003038] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
96 Rosca AE, Iesanu MI, Zahiu CDM, Voiculescu SE, Paslaru AC, Zagrean AM. Capsaicin and Gut Microbiota in Health and Disease. Molecules 2020;25:E5681. [PMID: 33276488 DOI: 10.3390/molecules25235681] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
97 Chakaroun RM, Massier L, Kovacs P. Gut Microbiome, Intestinal Permeability, and Tissue Bacteria in Metabolic Disease: Perpetrators or Bystanders? Nutrients 2020;12:E1082. [PMID: 32295104 DOI: 10.3390/nu12041082] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
98 Grill M, Hasenoehrl C, Kienzl M, Kargl J, Schicho R. Cellular localization and regulation of receptors and enzymes of the endocannabinoid system in intestinal and systemic inflammation. Histochem Cell Biol 2019;151:5-20. [PMID: 30196316 DOI: 10.1007/s00418-018-1719-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
99 Farzi A, Hassan AM, Zenz G, Holzer P. Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis. Mol Aspects Med 2019;66:80-93. [PMID: 30513310 DOI: 10.1016/j.mam.2018.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
100 Plovier H, Everard A, Druart C, Depommier C, Van Hul M, Geurts L, Chilloux J, Ottman N, Duparc T, Lichtenstein L, Myridakis A, Delzenne NM, Klievink J, Bhattacharjee A, van der Ark KC, Aalvink S, Martinez LO, Dumas ME, Maiter D, Loumaye A, Hermans MP, Thissen JP, Belzer C, de Vos WM, Cani PD. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23:107-113. [PMID: 27892954 DOI: 10.1038/nm.4236] [Cited by in Crossref: 685] [Cited by in F6Publishing: 617] [Article Influence: 114.2] [Reference Citation Analysis]
101 Boeri L, Donnaloja F, Campanile M, Sardelli L, Tunesi M, Fusco F, Giordano C, Albani D. Using integrated meta-omics to appreciate the role of the gut microbiota in epilepsy. Neurobiol Dis 2022;:105614. [PMID: 35017031 DOI: 10.1016/j.nbd.2022.105614] [Reference Citation Analysis]
102 Little TJ, Cvijanovic N, DiPatrizio NV, Argueta DA, Rayner CK, Feinle-Bisset C, Young RL. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion. Am J Physiol Endocrinol Metab 2018;315:E489-95. [PMID: 29438631 DOI: 10.1152/ajpendo.00355.2017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
103 Chen M, Hou P, Zhou M, Ren Q, Wang X, Huang L, Hui S, Yi L, Mi M. Resveratrol attenuates high-fat diet-induced non-alcoholic steatohepatitis by maintaining gut barrier integrity and inhibiting gut inflammation through regulation of the endocannabinoid system. Clin Nutr 2020;39:1264-75. [PMID: 31189495 DOI: 10.1016/j.clnu.2019.05.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 10.7] [Reference Citation Analysis]
104 Ortega MA, Fraile-Martínez O, Naya I, García-Honduvilla N, Álvarez-Mon M, Buján J, Asúnsolo Á, de la Torre B. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications. Nutrients 2020;12:E2749. [PMID: 32917030 DOI: 10.3390/nu12092749] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
105 Moludi J, Alizadeh M, Lotfi Yagin N, Pasdar Y, Nachvak SM, Abdollahzad H, Sadeghpour Tabaei A. New insights on atherosclerosis: A cross-talk between endocannabinoid systems with gut microbiota. J Cardiovasc Thorac Res 2018;10:129-37. [PMID: 30386532 DOI: 10.15171/jcvtr.2018.21] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
106 Ahmed I, Umar S. Microbiome and Colorectal Cancer. Curr Colorectal Cancer Rep 2018;14:217-25. [PMID: 33456404 DOI: 10.1007/s11888-018-0416-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
107 Zhang X, Zheng X, Yuan Y. Treatment of insulin resistance: straight from the gut. Drug Discovery Today 2016;21:1284-90. [DOI: 10.1016/j.drudis.2016.06.016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
108 Wilson NL, Peterson SN, Ellis RJ. Cannabis and the Gut-Brain Axis Communication in HIV Infection. Cannabis Cannabinoid Res 2021;6:92-104. [PMID: 33912676 DOI: 10.1089/can.2020.0037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Costiniuk CT, Jenabian MA. Reply to: Benefits of cannabis use for metabolic disorders and survival in people living with HIV with or without hepatitis C. AIDS 2020;34:955-6. [PMID: 32271255 DOI: 10.1097/QAD.0000000000002481] [Reference Citation Analysis]
110 Bisogno T, Lauritano A, Piscitelli F. The Endocannabinoid System: A Bridge between Alzheimer's Disease and Gut Microbiota. Life (Basel) 2021;11:934. [PMID: 34575083 DOI: 10.3390/life11090934] [Reference Citation Analysis]
111 Silva MH. Chlorpyrifos and Δ9 Tetrahydrocannabinol exposure and effects on parameters associated with the endocannabinoid system and risk factors for obesity. Curr Res Toxicol 2021;2:296-308. [PMID: 34467221 DOI: 10.1016/j.crtox.2021.08.002] [Reference Citation Analysis]
112 Yang Y, Tian A, Wu Z, Wei Y, Hu X, Guo J. Finger Citron Extract Ameliorates Glycolipid Metabolism and Inflammation by Regulating GLP-1 Secretion via TGR5 Receptors in Obese Rats. Evid Based Complement Alternat Med 2021;2021:6623379. [PMID: 33854556 DOI: 10.1155/2021/6623379] [Reference Citation Analysis]
113 Hasani A, Ebrahimzadeh S, Hemmati F, Khabbaz A, Hasani A, Gholizadeh P. The role of Akkermansia muciniphila in obesity, diabetes and atherosclerosis. J Med Microbiol 2021;70. [PMID: 34623232 DOI: 10.1099/jmm.0.001435] [Reference Citation Analysis]
114 Forte N, Fernández-Rilo AC, Palomba L, Di Marzo V, Cristino L. Obesity Affects the Microbiota-Gut-Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators. Int J Mol Sci 2020;21:E1554. [PMID: 32106469 DOI: 10.3390/ijms21051554] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
115 Di Marzo V, Silvestri C. Lifestyle and Metabolic Syndrome: Contribution of the Endocannabinoidome. Nutrients 2019;11:E1956. [PMID: 31434293 DOI: 10.3390/nu11081956] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 12.3] [Reference Citation Analysis]
116 San-Cristobal R, Navas-Carretero S, Martínez-González MÁ, Ordovas JM, Martínez JA. Contribution of macronutrients to obesity: implications for precision nutrition. Nat Rev Endocrinol 2020;16:305-20. [PMID: 32235875 DOI: 10.1038/s41574-020-0346-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
117 Uranga JA, Vera G, Abalo R. Cannabinoid pharmacology and therapy in gut disorders. Biochem Pharmacol 2018;157:134-47. [PMID: 30076849 DOI: 10.1016/j.bcp.2018.07.048] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
118 Yang Q, Ouyang J, Sun F, Yang J. Short-Chain Fatty Acids: A Soldier Fighting Against Inflammation and Protecting From Tumorigenesis in People With Diabetes. Front Immunol 2020;11:590685. [PMID: 33363537 DOI: 10.3389/fimmu.2020.590685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
119 Underwood MA, Sohn K. The Microbiota of the Extremely Preterm Infant. Clin Perinatol 2017;44:407-27. [PMID: 28477669 DOI: 10.1016/j.clp.2017.01.005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
120 Jasirwan COM, Lesmana CRA, Hasan I, Sulaiman AS, Gani RA. The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. Biosci Microbiota Food Health 2019;38:81-8. [PMID: 31384519 DOI: 10.12938/bmfh.18-032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
121 Febo E, Crisi PE, Oddi S, Pietra M, Galiazzo G, Piscitelli F, Gramenzi A, Prinzio RD, Di Tommaso M, Bernabò N, Bisogno T, Maccarrone M, Boari A. Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study. Front Vet Sci 2021;8:655311. [PMID: 34124221 DOI: 10.3389/fvets.2021.655311] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Markandey M, Bajaj A, Ilott NE, Kedia S, Travis S, Powrie F, Ahuja V. Gut microbiota: sculptors of the intestinal stem cell niche in health and inflammatory bowel disease. Gut Microbes 2021;13:1990827. [PMID: 34747326 DOI: 10.1080/19490976.2021.1990827] [Reference Citation Analysis]
123 Minichino A, Jackson MA, Francesconi M, Steves CJ, Menni C, Burnet PWJ, Lennox BR. Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort. Mol Psychiatry 2021. [PMID: 34002020 DOI: 10.1038/s41380-021-01147-5] [Reference Citation Analysis]
124 Taschler U, Hasenoehrl C, Storr M, Schicho R. Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance. Handb Exp Pharmacol 2017;239:343-62. [PMID: 28161834 DOI: 10.1007/164_2016_105] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
125 Dione N, Lacroix S, Taschler U, Deschênes T, Abolghasemi A, Leblanc N, Di Marzo V, Silvestri C. Mgll Knockout Mouse Resistance to Diet-Induced Dysmetabolism Is Associated with Altered Gut Microbiota. Cells 2020;9:E2705. [PMID: 33348740 DOI: 10.3390/cells9122705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
126 Kashyap S, Pal S, Chandan G, Saini V, Chakrabarti S, Saini NK, Mittal A, Thakur VK, Saini AK, Saini RV. Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers. Semin Cancer Biol 2021:S1044-579X(21)00121-8. [PMID: 33971261 DOI: 10.1016/j.semcancer.2021.04.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
127 Baptista LC, Sun Y, Carter CS, Buford TW. Crosstalk Between the Gut Microbiome and Bioactive Lipids: Therapeutic Targets in Cognitive Frailty. Front Nutr 2020;7:17. [PMID: 32219095 DOI: 10.3389/fnut.2020.00017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
128 Fellous T, De Maio F, Kalkan H, Carannante B, Boccella S, Petrosino S, Maione S, Di Marzo V, Iannotti FA. Phytocannabinoids promote viability and functional adipogenesis of bone marrow-derived mesenchymal stem cells through different molecular targets. Biochemical Pharmacology 2020;175:113859. [DOI: 10.1016/j.bcp.2020.113859] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
129 Mestre L, Carrillo-Salinas FJ, Mecha M, Feliú A, Guaza C. Gut microbiota, cannabinoid system and neuroimmune interactions: New perspectives in multiple sclerosis. Biochem Pharmacol 2018;157:51-66. [PMID: 30171835 DOI: 10.1016/j.bcp.2018.08.037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
130 Valle M, Mitchell PL, Pilon G, St-Pierre P, Varin T, Richard D, Vohl MC, Jacques H, Delvin E, Levy E, Gagnon C, Bazinet L, Marette A. Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice. J Nutr 2021;151:1175-89. [PMID: 33851198 DOI: 10.1093/jn/nxab002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
131 Kim D, Min Y, Suminda GGD, Hur CG, Lee SC, Lee HK, Song KD, Heo J, Son YO, Lee DS. Bacillus-supplemented diet improves growth performance in Jeju native pigs by modulating myogenesis and adipogenesis. Anim Biotechnol 2022;:1-13. [PMID: 35311492 DOI: 10.1080/10495398.2022.2047996] [Reference Citation Analysis]
132 Shaheen S, Shorbagi M, Lorenzo JM, Farag MA. Dissecting dietary melanoidins: formation mechanisms, gut interactions and functional properties. Crit Rev Food Sci Nutr 2021;:1-18. [PMID: 34137312 DOI: 10.1080/10408398.2021.1937509] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Shoubridge AP, Choo JM, Martin AM, Keating DJ, Wong ML, Licinio J, Rogers GB. The gut microbiome and mental health: advances in research and emerging priorities. Mol Psychiatry 2022. [PMID: 35236957 DOI: 10.1038/s41380-022-01479-w] [Reference Citation Analysis]
134 Plovier H, Cani PD. [Optimization and safety assessment of Akkermansia muciniphila for human administration]. Med Sci (Paris) 2017;33:373-5. [PMID: 28497729 DOI: 10.1051/medsci/20173304002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
135 Rodriguez J, Olivares M, Delzenne NM. Implication of the Gut Microbiota in Metabolic Inflammation Associated with Nutritional Disorders and Obesity. Mol Nutr Food Res 2021;65:e1900481. [PMID: 33111450 DOI: 10.1002/mnfr.201900481] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Zádor F, Nagy-Grócz G, Kekesi G, Dvorácskó S, Szűcs E, Tömböly C, Horvath G, Benyhe S, Vécsei L. Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions. Molecules 2019;24:E3709. [PMID: 31619006 DOI: 10.3390/molecules24203709] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
137 Suriano F, Manca C, Flamand N, Depommier C, Van Hul M, Delzenne NM, Silvestri C, Cani PD, Di Marzo V. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota. Biochim Biophys Acta Mol Cell Biol Lipids 2022;1867:159056. [PMID: 34606993 DOI: 10.1016/j.bbalip.2021.159056] [Reference Citation Analysis]
138 Joshi N, Onaivi ES. Psychiatric Disorders and Cannabinoid Receptors. Adv Exp Med Biol 2021;1264:131-53. [PMID: 33332008 DOI: 10.1007/978-3-030-57369-0_9] [Reference Citation Analysis]
139 Karoly HC, Mueller RL, Bidwell LC, Hutchison KE. Cannabinoids and the Microbiota-Gut-Brain Axis: Emerging Effects of Cannabidiol and Potential Applications to Alcohol Use Disorders. Alcohol Clin Exp Res 2020;44:340-53. [PMID: 31803950 DOI: 10.1111/acer.14256] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
140 Fulcher JA, Hussain SK, Cook R, Li F, Tobin NH, Ragsdale A, Shoptaw S, Gorbach PM, Aldrovandi GM. Effects of Substance Use and Sex Practices on the Intestinal Microbiome During HIV-1 Infection. J Infect Dis 2018;218:1560-70. [PMID: 29982500 DOI: 10.1093/infdis/jiy349] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
141 Satapathy SK, Banerjee P, Pierre JF, Higgins D, Dutta S, Heda R, Khan SD, Mupparaju VK, Mas V, Nair S, Eason JD, Kleiner DE, Maluf DG. Characterization of Gut Microbiome in Liver Transplant Recipients With Nonalcoholic Steatohepatitis. Transplant Direct 2020;6:e625. [PMID: 33204823 DOI: 10.1097/TXD.0000000000001033] [Reference Citation Analysis]
142 Forteza F, Giorgini G, Raymond F. Neurobiological Processes Induced by Aerobic Exercise through the Endocannabinoidome. Cells 2021;10:938. [PMID: 33920695 DOI: 10.3390/cells10040938] [Reference Citation Analysis]
143 Cani PD. Interactions between gut microbes and host cells control gut barrier and metabolism. Int J Obes Suppl 2016;6:S28-31. [PMID: 28685027 DOI: 10.1038/ijosup.2016.6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
144 van Orten-Luiten AB, de Roos NM, Majait S, Witteman BJM, Witkamp RF. Effects of Cannabidiol Chewing Gum on Perceived Pain and Well-Being of Irritable Bowel Syndrome Patients: A Placebo-Controlled Crossover Exploratory Intervention Study with Symptom-Driven Dosing. Cannabis Cannabinoid Res 2021. [PMID: 33998882 DOI: 10.1089/can.2020.0087] [Reference Citation Analysis]
145 Beckmann L, Künstner A, Freschi ML, Huber G, Stölting I, Ibrahim SM, Hirose M, Freitag M, Langan EA, Matschl U, Galuska CE, Fuchs B, Knobloch JK, Busch H, Raasch W. Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect. Pharmacol Res 2021;170:105724. [PMID: 34116209 DOI: 10.1016/j.phrs.2021.105724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Marcellin F, Fontaine H, Serfaty L, Sogni P, Carrieri MP. Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research. Expert Review of Anti-infective Therapy 2018;16:377-80. [DOI: 10.1080/14787210.2018.1473764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
147 Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol Hepatol 2017;2:747-56. [PMID: 28844808 DOI: 10.1016/S2468-1253(17)30147-4] [Cited by in Crossref: 185] [Cited by in F6Publishing: 100] [Article Influence: 37.0] [Reference Citation Analysis]
148 Scheithauer TP, Dallinga-Thie GM, de Vos WM, Nieuwdorp M, van Raalte DH. Causality of small and large intestinal microbiota in weight regulation and insulin resistance. Mol Metab 2016;5:759-70. [PMID: 27617199 DOI: 10.1016/j.molmet.2016.06.002] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 15.5] [Reference Citation Analysis]
149 Jordan BF, Gourgue F, Cani PD. Adipose Tissue Metabolism and Cancer Progression: Novel Insights from Gut Microbiota? Curr Pathobiol Rep 2017;5:315-22. [PMID: 29188139 DOI: 10.1007/s40139-017-0154-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
150 Tagliamonte S, Laiola M, Ferracane R, Vitale M, Gallo MA, Meslier V, Pons N, Ercolini D, Vitaglione P. Mediterranean diet consumption affects the endocannabinoid system in overweight and obese subjects: possible links with gut microbiome, insulin resistance and inflammation. Eur J Nutr 2021;60:3703-16. [PMID: 33763720 DOI: 10.1007/s00394-021-02538-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
151 Muñoz-garach A, Cornejo-pareja IM, Tinahones FJ. Gut Microbiota; Its Importance in Obesity. Encyclopedia of Endocrine Diseases. Elsevier; 2019. pp. 353-62. [DOI: 10.1016/b978-0-12-801238-3.65351-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
152 Ellermann M, Pacheco AR, Jimenez AG, Russell RM, Cuesta S, Kumar A, Zhu W, Vale G, Martin SA, Raj P, McDonald JG, Winter SE, Sperandio V. Endocannabinoids Inhibit the Induction of Virulence in Enteric Pathogens. Cell 2020;183:650-665.e15. [PMID: 33031742 DOI: 10.1016/j.cell.2020.09.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
153 Depommier C, Vitale RM, Iannotti FA, Silvestri C, Flamand N, Druart C, Everard A, Pelicaen R, Maiter D, Thissen JP, Loumaye A, Hermans MP, Delzenne NM, de Vos WM, Di Marzo V, Cani PD. Beneficial Effects of Akkermansia muciniphila Are Not Associated with Major Changes in the Circulating Endocannabinoidome but Linked to Higher Mono-Palmitoyl-Glycerol Levels as New PPARα Agonists. Cells 2021;10:185. [PMID: 33477821 DOI: 10.3390/cells10010185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
154 de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. [DOI: 10.1136/gutjnl-2021-326789] [Reference Citation Analysis]
155 Cohen LJ, Esterhazy D, Kim SH, Lemetre C, Aguilar RR, Gordon EA, Pickard AJ, Cross JR, Emiliano AB, Han SM, Chu J, Vila-Farres X, Kaplitt J, Rogoz A, Calle PY, Hunter C, Bitok JK, Brady SF. Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 2017;549:48-53. [PMID: 28854168 DOI: 10.1038/nature23874] [Cited by in Crossref: 185] [Cited by in F6Publishing: 178] [Article Influence: 37.0] [Reference Citation Analysis]
156 Piazza PV, Cota D, Marsicano G. The CB1 Receptor as the Cornerstone of Exostasis. Neuron 2017;93:1252-74. [PMID: 28334603 DOI: 10.1016/j.neuron.2017.02.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
157 Aizpurua-olaizola O, Elezgarai I, Rico-barrio I, Zarandona I, Etxebarria N, Usobiaga A. Targeting the endocannabinoid system: future therapeutic strategies. Drug Discovery Today 2017;22:105-10. [DOI: 10.1016/j.drudis.2016.08.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 13.0] [Reference Citation Analysis]
158 Bogale K, Raup-Konsavage W, Dalessio S, Vrana K, Coates MD. Cannabis and Cannabis Derivatives for Abdominal Pain Management in Inflammatory Bowel Disease. Med Cannabis Cannabinoids 2021;4:97-106. [PMID: 35224429 DOI: 10.1159/000517425] [Reference Citation Analysis]
159 Huo X, Li D, Wu F, Li S, Qiao Y, Wang C, Wang Y, Zhou C, Sun L, Luan Z, Yan Q, Wang J, Zhang Y, Zhao T, An Y, Zhang B, Tian X, Yu Z, Ma X. Cultivated human intestinal fungus Candida metapsilosis M2006B attenuates colitis by secreting acyclic sesquiterpenoids as FXR agonists. Gut 2022:gutjnl-2021-325413. [PMID: 35173042 DOI: 10.1136/gutjnl-2021-325413] [Reference Citation Analysis]
160 Fu X, Chen T, Cai J, Liu B, Zeng Y, Zhang X. The Microbiome-Gut-Brain Axis, a Potential Therapeutic Target for Substance-Related Disorders. Front Microbiol 2021;12:738401. [PMID: 34690981 DOI: 10.3389/fmicb.2021.738401] [Reference Citation Analysis]
161 Hua D, Li S, Li S, Wang X, Wang Y, Xie Z, Zhao Y, Zhang J, Luo A. Gut Microbiome and Plasma Metabolome Signatures in Middle-Aged Mice With Cognitive Dysfunction Induced by Chronic Neuropathic Pain. Front Mol Neurosci 2022;14:806700. [DOI: 10.3389/fnmol.2021.806700] [Reference Citation Analysis]
162 Fetissov SO. Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat Rev Endocrinol. 2017;13:11-25. [PMID: 27616451 DOI: 10.1038/nrendo.2016.150] [Cited by in Crossref: 162] [Cited by in F6Publishing: 140] [Article Influence: 27.0] [Reference Citation Analysis]
163 Cani PD, Van Hul M, Lefort C, Depommier C, Rastelli M, Everard A. Microbial regulation of organismal energy homeostasis. Nat Metab. 2019;1:34-46. [PMID: 32694818 DOI: 10.1038/s42255-018-0017-4] [Cited by in Crossref: 131] [Cited by in F6Publishing: 97] [Article Influence: 43.7] [Reference Citation Analysis]
164 Yu M, Jia HM, Qin LL, Zou ZM. Gut microbiota and gut tissue metabolites involved in development and prevention of depression. J Affect Disord 2022;297:8-17. [PMID: 34666115 DOI: 10.1016/j.jad.2021.10.016] [Reference Citation Analysis]
165 Cani PD, Jordan BF. Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2018;15:671-682. [PMID: 29844585 DOI: 10.1038/s41575-018-0025-6] [Cited by in Crossref: 104] [Cited by in F6Publishing: 102] [Article Influence: 34.7] [Reference Citation Analysis]
166 Suriano F, Bindels LB, Verspreet J, Courtin CM, Verbeke K, Cani PD, Neyrinck AM, Delzenne NM. Fat binding capacity and modulation of the gut microbiota both determine the effect of wheat bran fractions on adiposity. Sci Rep. 2017;7:5621. [PMID: 28717237 DOI: 10.1038/s41598-017-05698-y] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
167 Lovecchio F, Langhans MT, Bennett T, Steinhaus M, Premkumar A, Cunningham M, Farmer J, Albert T, Huang R, Katsuura Y, Qureshi S, Schwab F, Sandhu H, Kim HJ, Lafage V, Iyer S. Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey. Int J Spine Surg 2021;15:663-8. [PMID: 34285125 DOI: 10.14444/8087] [Reference Citation Analysis]
168 Basson AR, Lam M, Cominelli F. Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. Gastroenterol Clin North Am. 2017;46:689-729. [PMID: 29173517 DOI: 10.1016/j.gtc.2017.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
169 Sircana A, Framarin L, Leone N, Berrutti M, Castellino F, Parente R, De Michieli F, Paschetta E, Musso G. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence? Curr Diab Rep. 2018;18:98. [PMID: 30215149 DOI: 10.1007/s11892-018-1057-6] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 16.0] [Reference Citation Analysis]
170 Baiden-Amissah REM, Tuyaerts S. Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity. Int J Mol Sci 2019;20:E3586. [PMID: 31340438 DOI: 10.3390/ijms20143586] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
171 Gugliandolo E, Peritore AF, Piras C, Cuzzocrea S, Crupi R. Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing. Vet Sci 2020;7:E78. [PMID: 32560159 DOI: 10.3390/vetsci7020078] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
172 Fetissov SO, Averina OV, Danilenko VN. Neuropeptides in the microbiota-brain axis and feeding behavior in autism spectrum disorder. Nutrition 2019;61:43-8. [PMID: 30684851 DOI: 10.1016/j.nut.2018.10.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
173 Mehmood K, Moin A, Hussain T, Rizvi SMD, Gowda DV, Shakil S, Kamal MA. Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management? Folia Microbiol (Praha) 2021;66:897-916. [PMID: 34699042 DOI: 10.1007/s12223-021-00926-5] [Reference Citation Analysis]
174 Di Paola M, Bonechi E, Provensi G, Costa A, Clarke G, Ballerini C, De Filippo C, Passani MB. Oleoylethanolamide treatment affects gut microbiota composition and the expression of intestinal cytokines in Peyer's patches of mice. Sci Rep 2018;8:14881. [PMID: 30291258 DOI: 10.1038/s41598-018-32925-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
175 Voorhies AA, Mark Ott C, Mehta S, Pierson DL, Crucian BE, Feiveson A, Oubre CM, Torralba M, Moncera K, Zhang Y, Zurek E, Lorenzi HA. Study of the impact of long-duration space missions at the International Space Station on the astronaut microbiome. Sci Rep 2019;9:9911. [PMID: 31289321 DOI: 10.1038/s41598-019-46303-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 12.7] [Reference Citation Analysis]
176 de Cossío LF, Fourrier C, Sauvant J, Everard A, Capuron L, Cani PD, Layé S, Castanon N. Impact of prebiotics on metabolic and behavioral alterations in a mouse model of metabolic syndrome. Brain Behav Immun 2017;64:33-49. [PMID: 28027925 DOI: 10.1016/j.bbi.2016.12.022] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]